Drug Study
Drug Study
Drug Study
DRUG STUDY
Name of Drug Action Indication Contraindication Adverse Reaction Health Teaching
Gentamycin Bactericidal: Serious Contraindicated CNS: Ototoxicity-tinnitus, Client may
inhibits infections with allergy to any dizziness, vertigo, experience side
protein caused by aminoglycosides deafness (partially effects, such as:
susceptible ringing in the ears,
synthesis in Use cautiously with reversible to
strains of headache, dizziness
susceptible renal or hepatic irreversible), vestibular
Pseudomonas (reversible; use
strains of aeruginosa, disease; sulfite paralysis, confusion, safety measures if
gram- Proteus species, sensitivity; pre- disorientation, severe), nausea,
negative E. coli, existing hearing depression, lethargy, vomiting, loss of
bacteria; Klebsiella- loss; active nystagmus, visual appetite (eat
appears to Enterobacter- infection with disturbances, headache, frequent small
Serratia species, meals, perform
disrupt herpes, vaccinia, numbness, tingling,
Citrobacter, frequent mouth
functional Staphylococcus varicella, fungal tremor, paresthesia,
care)
integrity of species infections, muscle twitching, Report pain at
bacterial cell Serious mycobacterial seizures, muscular injection site,
membrane, infections when infections weakness, severe headache,
causing cell causative (ophthalmic neuromuscular blockade dizziness, loss of
death organisms are preparations); CV: Palpitations, hearing, changes in
not known urine pattern,
myasthenia gravis; hypertension,
(often in difficulty breathing,
conjunction parkinsonism; hypotension
rash or skin lesions
with a penicillin infant botulism; GI: hepatic toxicity,
or burn patients; nausea, vomiting,
cephalosporin) lactation, anorexia, weight loss,
Unlabeled used: pregnancy stomatitis, increased
with salivation
clindamycin as
GU: nephrotoxicity
alternative
regimen in PID. Hematologic: Leukemoid
reaction,
agranulocytosis,
granulocytosis,
leucopenia, leukocytosis,
thrombocytopenia,
eosinophilia,
pancytopenia, anemia,
hemolytic anemia,
increased or decreased
reticulocyte count,
electrolyte disturbances
Hypersensitivity:
Purpura, rash, urticaria,
exfoliative dermatitis,
itching
Local: pain, irritation,
arachnoiditis at IM
injection sites
Other: fever, apnea,
splenomegaly, joint pain,
superinfections
DRUG STUDY
DRUG STUDY